Notch signaling: A hero or villain in the war against cancer?

Translational Lung Cancer Research

Volumn 2, Issue 6, 2013, Pages 449-451

  Chikara, Shireen ^a   Reindl, Katie M ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Dll4; Lung cancer; Notch; PI3K

Indexed keywords

EID: 84948437190     PISSN: 22186751     EISSN: 22264477     Source Type: Journal    
DOI: 10.3978/j.issn.2218-6751.2013.10.15     Document Type: Article

References (18)

1. Kwon SM, Alev C, Lee SH, et al. The molecular basis of Notch signaling: a brief overview. Adv Exp Med Biol 2012;727:1-14.
2. Borggrefe T, Oswald F. The Notch signaling pathway: transcriptional regulation at Notch target genes. Cell Mol Life Sci 2009;66:1631-46.
3. Schweisguth F. Regulation of notch signaling activity. Curr Biol 2004;14:R129-38.
4. Ranganathan P, Weaver KL, Capobianco AJ. Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer 2011;11:338-51.
5. Xu P, Yu S, Jiang R, et al. Differential expression of Notch family members in astrocytomas and medulloblastomas. Pathol Oncol Res 2009;15:703-10.
6. Stylianou S, Clarke RB, Brennan K. Aberrant activation of notch signaling in human breast cancer. Cancer Res 2006;66:1517-25.
7. Santagata S, Demichelis F, Riva A, et al. JAGGED1 expression is associated with prostate cancer metastasis and recurrence. Cancer Res 2004;64:6854-7.
8. Miyamoto Y, Maitra A, Ghosh B, et al. Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell 2003;3:565-76.
9. Meurette O, Stylianou S, Rock R, et al. Notch activation induces Akt signaling via an autocrine loop to prevent apoptosis in breast epithelial cells. Cancer Res 2009;69:5015-22.
10. Dai J, Ma D, Zang S, et al. Cross-talk between Notch and EGFR signaling in human breast cancer cells. Cancer Invest 2009;27:533-40.
11. Maniati E, Bossard M, Cook N, et al. Crosstalk between the canonical NF-?B and Notch signaling pathways inhibits Ppar? expression and promotes pancreatic cancer progression in mice. J Clin Invest 2011;121:4685-99.
12. Parr C, Watkins G, Jiang WG. The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer. Int J Mol Med 2004;14:779-86.
13. Qi R, An H, Yu Y, et al. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. Cancer Res 2003;63:8323-9.
14. Ding XY, Ding J, Wu K, et al. Cross-talk between endothelial cells and tumor via delta-like ligand 4/Notch/PTEN signaling inhibits lung cancer growth. Oncogene 2012;31:2899-906.
15. Scehnet JS, Jiang W, Kumar SR, et al. Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion. Blood 2007;109:4753-60.
16. Noguera-Troise I, Daly C, Papadopoulos NJ, et al. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 2006;444:1032-7.
17. Liu ZJ, Xiao M, Balint K, et al. Notch1 signaling promotes primary melanoma progression by activating mitogenactivated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression. Cancer Res 2006;66:4182-90.
18. Collins BJ, Kleeberger W, Ball DW. Notch in lung development and lung cancer. Semin Cancer Biol 2004;14:357-64.